Join
Live feed
·
PRReleasevia Quantisnow
CRISPR Therapeutics AG logo
Vertex Pharmaceuticals Incorporated logo

Vertex and CRISPR Therapeutics Announce Acceptance of Late-Breaking Abstract for CTX001™ at the 2022 Annual European Hematology Association (EHA) Congress

ByQuantisnow·Wall Street's wire, on your screen.